Home › Stocks › HRTX

Heron Therapeutics, Inc. /De/ (HRTX): insider buying, hedge funds & Congress trades

Heron Therapeutics, Inc. /De/ (HRTX): 2 insider purchases in the last two years; 1 trade disclosed by members of Congress.

Insider buying

FiledInsiderSharesPriceValueType
Aug 12, 2025Morgan Adam
Director
1,766,546$1.50$2.6Mno history
Aug 12, 2025Rosen David Efraim
TenPercentOwner
2,387,225$1.50$3.6Mno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for HRTX

Free account. Know when insiders, famous funds or Congress trade it.

Start free

Congress trades in HRTX

FiledMemberTypeAmount
Apr 5, 2021Ashley Hinson Arenholzsale$1,001 - $15,000 g